Feasibility of Fabric Orthosis for Knee Support in Elderly Gait Improvement
NCT ID: NCT06387459
Last Updated: 2025-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2024-07-31
2026-05-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Determine the Gait and Functional Improvement in Total Knee Arthroplasty
NCT04057885
Active Knee Prosthesis Study for Improvement of Locomotion for Above Knee Amputees
NCT00771589
Clinical Efficacy and Safety of Robot-assisted Total Knee Arthroplasty
NCT06856356
Effects of Microprocessor-controlled Prosthetic Knees on Fall-related Health Outcomes in Limited Community Ambulators
NCT06937242
Oxford Partial Knee Kinematics Gait Analysis Study
NCT01454908
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Primary Objective: To evaluate the safety and feasibility of the fabric-type knee extensor muscle-mimicking orthosis in improving gait among elderly patients.
* Secondary Objectives: To measure changes in walking speed, endurance, and muscle activity to infer potential benefits in daily mobility.
Study Design:
* Study Population: 30 elderly patients suffering from conditions affecting mobility (sarcopenia, diabetes, knee osteoarthritis).
* Intervention: Use of a fabric-type orthosis mimicking knee extensor function, equipped with shape-memory alloy for dynamic movement support.
* Methodology:
1. Training and Adaptation: Participants will undergo an initial training session to get accustomed to the orthosis, including donning and doffing, adjustment, and use in various environments (flat surfaces, inclines).
2. Assessment Protocol:
* Before wearing the orthosis-after wearing the orthosis (power off)-after wearing the orthosis (power on)
* Walking environment will include EMG (Electromyography) measurements, 6-minute walk test, 10-meter walk test, and comprehensive gait analysis using platforms like the GAITRite system.
* Seating environment will include EMG (Electromyography) measurements and TUG test. 3. Safety Monitoring: Continuous monitoring of physiological responses (blood pressure, heart rate), musculoskeletal assessments, and skin integrity checks to monitor for adverse reactions or discomfort
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Knee Extensor Muscle-Mimicking Orthosis
This arm involves participants wearing a novel, lightweight fabric-type orthosis designed to mimic the function of knee extensor muscles through embedded shape-memory alloys. This intervention aims to support the knee joint during gait, enhancing stability and mobility for elderly individuals with compromised muscle function.
Fabric-Type Knee Extensor Muscle-Mimicking Orthosis
The intervention device is a fabric-based orthosis incorporating shape-memory alloy springs designed to mimic the action of knee extensor muscles. The primary function of this orthosis is to provide supplementary support to the knee joint during walking, aiming to stabilize the gait of elderly individuals affected by muscle weakness or degenerative joint conditions. Material: The orthosis is made from a lightweight, flexible fabric that allows for breathability and comfort during extended wear. Mechanism: Embedded within the fabric are shape- memory alloy springs that function similarly to biological muscles.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fabric-Type Knee Extensor Muscle-Mimicking Orthosis
The intervention device is a fabric-based orthosis incorporating shape-memory alloy springs designed to mimic the action of knee extensor muscles. The primary function of this orthosis is to provide supplementary support to the knee joint during walking, aiming to stabilize the gait of elderly individuals affected by muscle weakness or degenerative joint conditions. Material: The orthosis is made from a lightweight, flexible fabric that allows for breathability and comfort during extended wear. Mechanism: Embedded within the fabric are shape- memory alloy springs that function similarly to biological muscles.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Age: Participants must be 65 years of age or older.
2. Comprehension and Compliance: Able to fully understand and comply with the instructions and study procedures.
3. Mobility-Impacting Conditions: Must have at least one of the following conditions affecting mobility: (1)Sarcopenia:
* Muscle Strength: Handgrip strength of \<28 kg for men and \<18 kg for women.
* Muscle Function: Short Physical Performance Battery (SPPB) score of 8 or less.
* Muscle Mass: Bioelectrical impedance analysis (BIA) showing muscle mass \<7.0 kg/m² for men and \<5.7 kg/m² for women. (2)Diabetes:
* Diagnosed distal symmetric polyneuropathy.
* Sensory impairments in toes or feet. (3)Knee Osteoarthritis:
* Kellgren-Lawrence grade ≥2.
* Persistent pain (≥3 months) with a severity of at least 3 on the Numerical Rating Scale (NRS).
Exclusion Criteria
1. Inability to Consent: Unable to provide informed consent or not willing to participate in the study procedures.
2. Severe Sensory or Motion Limitations: Including severe visual or vestibular impairments that could increase the risk of falling.
3. Communication Barriers: Significant hearing, speech, or language problems that would hinder communication with study personnel.
4. Independent Walking Inability: Cannot walk independently without the aid of a walking device.
5. Other Significant Diseases or Conditions:
* Neurological disorders that affect walking ability (e.g., stroke, Parkinson's disease).
* Orthopedic or musculoskeletal conditions severely affecting lower limb function.
* Severe cardiovascular conditions including uncontrolled hypertension or heart failure.
* Respiratory diseases requiring regular oxygen therapy.
* Active cancer treatment or cancer treatment within the past 3 years (except basal cell carcinoma or localized prostate cancer).
* Severe psychiatric disorders like schizophrenia or bipolar disorder.
6. Other Exclusionary Factors:
* Past severe orthopedic surgeries on lower limbs which might affect gait and mobility.
* Severe back pain or any other condition affecting mobility not already listed.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Science and ICT, Republic of Korea
OTHER_GOV
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hyungik shin, prof
Role: PRINCIPAL_INVESTIGATOR
Seoul National University Hospital
Woo Hyung Lee, prof
Role: STUDY_DIRECTOR
Seoul National University Hospital
Jung hyun Kim, prof
Role: STUDY_DIRECTOR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, Jongno, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022M3C1A3090827
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.